Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.
De Filippi P
Br J Haematol. 2009 Sep 22;147(5):706-9. doi: 10.1111/j.1365-2141.2009.07894.x
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments.
Righi M
Lab Invest. 2009 Aug 3;89(9):1063-70. doi: 10.1038/labinvest.2009.76
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).
Chiesa C
Eur J Nucl Med Mol Imaging. 2009 May 20;36(11):1745-57. doi: 10.1007/s00259-009-1141-x
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.
Dodero A
Blood. 2009 Feb 11;113(19):4771-9. doi: 10.1182/blood-2008-10-183723
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
Magni M
Bone Marrow Transplant. 2008 Oct 27;43(6):509-11. doi: 10.1038/bmt.2008.349
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.
Di Nicola M
Blood. 2008 Sep 22;113(1):18-27. doi: 10.1182/blood-2008-06-165654
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.
Devizzi L
J Clin Oncol. 2008 Oct 14;26(32):5175-82. doi: 10.1200/JCO.2008.16.8294
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R
Haematologica. 2008 Aug 25;93(10):1523-34. doi: 10.3324/haematol.12521
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.
Lavazza C
Exp Hematol. 35(6):888-97.
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir.
Rocci A
Exp Hematol. 35(4):673-81.